HomeGERN • NASDAQ
add
Geron Corp
Previous close
$1.23
Day range
$1.21 - $1.30
Year range
$1.04 - $4.05
Market cap
817.09M USD
Avg Volume
7.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 47.23M | 67.05% |
Operating expense | 39.00M | 8.71% |
Net income | -18.43M | 30.32% |
Net profit margin | -39.02 | 58.29% |
Earnings per share | -0.03 | 25.00% |
EBITDA | -13.76M | 51.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 380.53M | 12.00% |
Total assets | 567.38M | 27.52% |
Total liabilities | 318.68M | 108.74% |
Total equity | 248.71M | — |
Shares outstanding | 638.36M | — |
Price to book | 3.15 | — |
Return on assets | -6.19% | — |
Return on capital | -9.23% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -18.43M | 30.32% |
Cash from operations | -13.58M | 76.97% |
Cash from investing | 13.35M | 2,509.39% |
Cash from financing | 542.00K | -84.85% |
Net change in cash | 389.00K | 100.70% |
Free cash flow | -7.44M | 85.12% |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
229
